- 演講或講座
- 生物醫學科學研究所
- 地點
生醫所地下室B1B演講廳
- 演講人姓名
陳沛隆 博士 (台大)
- 活動狀態
確定
- 活動網址
Next-generation sequencing (NGS) has transformed medical genomics, yet many clinically important genes remain incompletely resolved. These include some of the most complex and polymorphic genes in the human genome, representing a critical frontier where technical advances can yield substantial biological and clinical rewards.
“Stars” refers to the star alleles of human leukocyte antigen (HLA), cytochrome P450 (CYP), killer cell immunoglobulin-like receptor (KIR), and germline adaptive immune receptor repertoire (gAIRR) genes—the genes encoding B-cell receptors (BCRs) and T-cell receptors (TCRs). Their extraordinary allelic diversity and complex genomic architecture create formidable analytical challenges while making them essential targets for understanding drug responses, immune function, and disease susceptibility. “Capture” carries a methodological meaning: capture-based targeted sequencing enriches these important loci for detailed characterization.
“Black holes” denotes “dark genes and dark regions” whose sequences, alleles, or structures cannot be clearly resolved by conventional sequencing and analytical workflows. These include the star-allele genes themselves, genes with highly similar homologs or pseudogenes, genes with repeat expansions, and other challenging loci. The stars and black holes therefore overlap, and these black holes contain many medically important targets whose full characterization remains challenging. Despite substantial progress, important gaps remain.
This talk presents complementary strategies to capture the stars and read through the black holes. Capture-based enrichment, specialized short-read sequencing strategies, long-read sequencing, and purpose-built bioinformatics each contribute to resolving complex loci. Their integration enables more comprehensive characterization of alleles, haplotypes, and structural variation. Examples from pharmacogenomics, immunogenomics, and genetic diagnosis will connect these methodological approaches to biological questions and clinical challenges.
Beyond clinical applications, these approaches provide powerful tools for fundamental research and mechanistic investigation, illuminating how genomic diversity shapes molecular function, immune responses, and disease. Addressing these partially solved problems can advance both discovery and precision medicine, turning persistent genomic blind spots into opportunities for deeper understanding and meaningful medical progress.
首頁